Relationship of blood levels of inflammatory and destructive biomarkers in coronary atherosclerosis with long-term results of surgical revascularization

Bulletin of Experimental Biology and Medicine

Volumn 155, Issue 3, 2013, Pages 314-317

  Ragino, Yu I ^a   Chernyavskiy, A M ^b   Tsimbal, S Yu ^b   Shcherbakova, L V ^a   Polonskaya, Ya V ^a   Kashtanova, E V ^a  

^a INSTITUTE OF PHYSIOLOGY   (Russian Federation)

^b MESHALKIN NATIONAL MEDICAL RESEARCH CENTER   (Russian Federation)

Author keywords

coronary atherosclerosis; coronary bypass surgery; highly sensitive C reactive protein; inflammatory and destructive biomarkers; long term results

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CD40 LIGAND; GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY RECANALIZATION; DEATH; DISEASE COURSE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; SENSITIVITY ANALYSIS; TRANSLUMINAL VALVULOPLASTY; ANALYSIS OF VARIANCE; BLOOD; CORONARY ARTERY DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; INFLAMMATION; MIDDLE AGED; PROCEDURES; RUSSIAN FEDERATION; TREATMENT OUTCOME;

ANGINA;

AGED; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CORONARY ARTERY DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; RUSSIA; TREATMENT OUTCOME;

EID: 84881122019     PISSN: 00074888     EISSN: 15738221     Source Type: Journal    
DOI: 10.1007/s10517-013-2142-0     Document Type: Article

References (15)

1. Yu. N. Belenkov, R. S. Akchurin, A. P. Savchenko, et al., Kardiologiya, 42, No. 5, 42-47 (2002).
2. L. A. Bokeriya, I. N. Stupakov, and I. V. Samorodskaya, Byull. Nauch. Tsentra Serdechno-Sosudistoi Khirurgii Im. Bakuleva, 2, No. 5, 16-50 (2001).
3. Yu. I. Ragino, A. M. Chernyavski, Ya. V. Polonskaya, et al., Bull. Exp. Biol. Med., 153, No. 2, 186-189 (2012).
4. Yu. I. Ragino, A. M. Chernjavski, Ya. V. Polonskaja, et al., Bull. Exp. Biol. Med., 149, No. 5, 587-590 (2010).
5. E. J. Armstrong, D. A. Morrow, and M. S. Sabatine, Circulation, 113, No. 6, e72-e75 (2006).
6. E. J. Armstrong, D. A. Morrow, and M. S. Sabatine, Circulation, 113, No. 9, e382-e385 (2006).
7. L. M. Biasucci, Circulation, 110, No. 25, e560-e567 (2004).
8. G. A. Bonaterra, S. Zugel, and R. Kinscherf, Curr. Mol. Med., 10, No. 2, 180-205 (2010).
9. M. Bucova, M. Bernadic, and T. Buckingham, Bratisl. Lek. Listy, 109, No. 8, 333-340 (2008).
10. J. P. Empana, F. Canoui-Poitrine, G. Luc, et al., Eur. Heart J., 29, No. 16, 1966-1974 (2008).
11. J. C. Fruchart, Pathophysiology of Stages of Development of Atherosclerosis. Handbook of Dyslipidemia and Atherosclerosis, Lille (2003), Pt. 1, pp.1-65.
12. Y. S. Kwok, C. Kim, and P. A. Heidenreich, Am. J. Med., 111, No. 2, 89-95 (2001).
13. E. Lubos, R. Schnabel, H. J. Rupprecht, et al., Eur. Heart J., 27, No. 2, 150-156 (2006).
14. R. Sukhija, I. Fahdi, L. Garza, et al., Am. J. Cardiol., 99, No. 7, 879-884 (2007).
15. N. Varo, J. A. de Lemos, P. Libby, et al., Circulation, 108, No. 9, 1049-1052 (2003).